Products / HGH Fragment 176-191

HGH FRAGMENT 176-191 labelled vial

HGH Fragment 176-191 2 mg

A growth-hormone-derived peptide segment.

CAD $35.00 / vial

Vial amount

Add to cart Ask about this product

The specifics, clearly listed.

Product details

Product reference: MRD-0077 Listed amount per vial: 2 mg Sales unit: 1 vial

Read the research in context.

A growth-hormone-derived peptide segment.

  • Human Growth Hormone Fragment 176–191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells — source

Candidate-molecule or reference-product background; not verification of this supplied product.

What this doesn’t establish: Do not equate native 176–191, 177–191 and modified AOD9604. Supplier sequence, N-terminal residue, disulfide pattern and terminal chemistry are needed. The 2022 paper itself describes a terminal-residue substitution in its background; its title alone must not be treated as proof of a native-fragment identity. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.

Product documents

No verified report is available here for this item. Ask about documentation for HGH Fragment 176-191, product reference MRD-0077.

Before you decide.

Separate research about the compound from evidence about the supplied product.

Which vial amount is shown?

This listing shows 2 mg per vial.

Does the study verify this vial?

No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.

What should I check in a report?

Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.

What information should I request?

Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.